drugset / Trial / NCT07292571
Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107
Phase 2
Enrolling by invitation
50 enrolled
Tomsk National Research Medical Center of the Russian Academy of Sciences
Uppsala University · collab
Non-randomizedParallel-groupSingle-blindDiagnostic
Summary
The study should evaluate the \[99mTc\]Tc -ZHER2:4107 accumulation in primary tumour of breast cancer patients with different HER2 expression
Timeline
- Start
- 2025-10-20
- Primary completion
- 2026-03-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [99mTc]Tc-ZHER2:4107 | Diagnostic / imaging agent | — | — |